Property:Dosage and regime
This is a property of type Text.
J
Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain +
NI +
Jyothirmayi et al. (1996): Efficacy of Vitamin A in the Prevention of Locoregional Recurrence and Second Primaries in Head and Neck Cancer +
Oral vitamin A 200,000 IU per week as chewable tablets of retinyl palmitate +
Jyothirmayi et al. (1996): Efficacy of Vitamin A in the Prevention of Locoregional Recurrence and Second Primaries in Head and Neck Cancer +
Oral capsules with tapioca powder +
K
Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 +
Daily +
Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 +
200 µg daily +
Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer +
3x5 tablets of Wobenzym daily for 6.5 weeks
+ all patients: 2x daily CDT (combined decongestive therapy) for the first 20 days, consisting of manual lymphatic drainage (neck, arm, thorax), bandaging of the arm, specially tailored exercises and skin care +
Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer +
+ All patients: 2x daily CDT (combined decongestive therapy) for the first 20 days, consisting of manual lymphatic drainage (neck, arm, thorax), bandaging of the arm, specially tailored exercises and skin care +
Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer +
Vaginal suppositories containing 1 mg of vitamin E plus 2 g of the base substance, every day before bedtime +
Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer +
Vaginal suppositories containing 2 g of the base substance plus 1000 IU of vitamin D (0.025 mg), every day before bedtime +
Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer +
Vaginal suppositories containing only 2 g of the base substance, every day before bedtime +
Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial +
The ointment was applied twice daily for six weeks by patients at home
+ all tumors were excised after eight weeks +
Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial +
The ointment was applied twice daily for six weeks by patients at home
+ all tumors were excised after eight weeks +
Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial +
Three capsules of 10,000 IU Vitamin D3 weekly
+ all patients: 1200 mg of calcium plus 600 IU of vitamin D daily (‘‘standard supplementation’’) and Letrozole 2.5 mg PO daily +
Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial +
Three capsules of placebo weekly
+ all patients: 1200 mg of calcium plus 600 IU of vitamin D daily (‘‘standard supplementation’’) and Letrozole 2.5 mg PO daily +
Khodabakhshi et al. (2019): Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study +
Medium-chain triglycerides (MCT) based ketogenic diet (6% calories from carbohydrates, 19% protein, 20% MCT, 55% fat); patients were given 500ml MCT oil from “Nutricia Company” every 2 weeks +
Khodabakhshi et al. (2019): Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study +
Standard diet (55% carbohydrates, 15% protein, and 30% fat) +
Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial +
4200 mg/day (3x4 capsules/day)
Starting with the first day of radiotherapy,
Ending with the last day of radiotherapy +
Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial +
84 capsules for 1 week (3x4 capsules/day starting with the first day of radiotherapy) +
Konmun et al. (2017): A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy +
2x2 6-gingerol capsules daily (5mg each, standardized), from 3 days before chemotherapy for 12 weeks or until the end of chemotherapy +
Konmun et al. (2017): A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy +
2x 2 Placebo capsules daily, from 3 days before chemotherapy for 12 weeks or until the end of chemotherapy +